linkedin post 2013-04-23 15:33:14

Uncategorized
MOLECULAR ROBOTS FOR DRUG DELIVERY are really Smart Materials which respond to signals like pH, light, electric current, and other physiological signals including specific proteins, to cause a mechanical change in conformation that can release a drug payload. Future drugs will employ Molecular Robots or be Intelligent Drugs. There is enormous room for innovating on this blank sheet of paper and transforming the delivery of medicines. http://lnkd.in/NU79fJ View in LinkedIn
Read More

linkedin post 2013-04-22 04:04:35

Uncategorized
ALLIANCES AND MERGERS BETWEEN SMEs TODAY MAKES SENSE, especially in the Biopharma sector. VCs have withdrawn, and Big Pharma is bearing the weight of solicitations, but is overwhelmed and the response times have become ridiculous. Most companies looking for collaborations and capital have failed to explore the layers of smaller companies below the giants. Many have capital, many are active in BD, and are interested in product licenses and filling their pipelines. In this economic climate, it is inevitable that market efficiencies will lead to combined similar programs. View in LinkedIn
Read More

linkedin post 2013-04-23 15:12:59

Uncategorized
CATALUNYA IN SPAIN PUNCHES ABOVE ITS WEIGHT IN TOP SCIENCE PUBLICATIONS. This is because some visionary public figures took the initiative 20 years ago to place a bet on excellence in science translating to powerful new companies. The society has invested heavily in research, and the first fruit is a remarkable quality publication rate. From this hundreds of SMEs have been seeded. This flammable mix just needs one success to be like Boston in 1989, when the world took notice of biotech and IT. This patient bet is about to pay off. View in LinkedIn
Read More

linkedin post 2013-04-21 05:14:28

Uncategorized
STEPHEN HAWKIN IS A SYMBOL OF THE POSSIBLE. ALS has ravaged his body, but this brilliant person lives an active cerebral life by communicating by a computer through eye movements only. We all know who he is. He has quietly entered every household. But the remarkable brain-computer interface that makes all this possible is something we have appeared uncurious about. This is more than a prototype. But what is that like subjectively? What is it like to have an athlete's brain and no body? What are the possibilities of hooking up a brain to a machine? View in LinkedIn
Read More

linkedin post 2013-04-20 07:00:02

Uncategorized
INDIA IS FIGURING OUT ITS IP POLICY as this thoughtful commentary outlines. It has been clear to me for some years that Indian pharmaceutical patents are very shrewd, and also that the IP industry including patent challenges are sophisticated. The key is to not cave to Activist views and keep the middle ground where patented innovator drugs from abroad are respected under patent treaties, and also to develop a sensible way to get approved Western drugs through Indian trials while not becoming a case for The Constant Gardener. P http://lnkd.in/pqYStD View in LinkedIn
Read More

linkedin post 2013-04-23 14:27:54

Uncategorized
WAVE POWER INITIATIVES ARE ALL OVER THE WORLD, and kicked off in about 1998 in Scotland and then 2008 with a Wave Farm off Portugal. Some estimate that waves could generate 10 trillion Watts of power. Gavin Newsome, former mayor of San Francisco, proposed a giant turbine under the Golden Gate Bridge, but nothing has happened. Theoretically, clean energy, with huge production potential is possible from wave farms. Curiously, this industry is in its infancy, and still a way away from attracting investors. View in LinkedIn
Read More

linkedin post 2013-04-20 06:30:49

Uncategorized
THE LEAN STARTUP METHOD is about adopting an experimental method in the search for customer access. This makes perfect sense for some companies but not for technology companies who are years away from a product and are unlikely ever to meet the customer. Specialty Pharma companies have years of formulation, preclinical testing, and eventually clinical trials to get a licensable product. Overall, the steps are pretty clear, although the outcomes are not. In these cases, a well-articulated plan of the steps and costs are valuable (flexible) roadmaps, and product forecasts will always be wrong. http://lnkd.in/EQumPg View in LinkedIn
Read More